Experienced Leadership Team

Joseph (Jay) Hagan

President and Chief Executive Officer
  • Previously Mr. Hagan was President and Chief Executive Officer of Regulus Therapeutics from 2017 to 2025.

Gail Cawkwell, MD, PhD

Chief Medical Officer
  • Dr. Gail Cawkwell has nearly 25 years of pharmaceutical industry experience and has held prior CMO roles, most recently at Aclaris Therapeutics

Mike Cruse

Chief Operating Officer
  • Executive Director of Commercial Operations at Avanir Pharmaceuticals through $3.5 billion acquisition by Otsuka

Kunal Kishnani

SVP Corporate Development
  • Founder & CEO of Warden Bio (acquired by Kriya Therapeutics)

Jennifer Lam

SVP Finance and Administration
  • Dynamic and innovative finance professional with 15+ years advancement and achievement

Board of Directors

Keith Katkin

Chairman of Ambros Therapeutics

Vivek Ramaswamy

Co-Founder and Board Member

Jay Hagan

Ambros Therapeutics Chief Executive Officer

Matthew Hammond, Ph.D.

RA Capital Management

Trit Garg, M.D.

Patient Square Capital

Prisca Di Martino

Abiogen Pharma

Investors

Loading...